7 rezultatet
TECHNICAL FIELD
The present invention relates to development of an antiulcer herbal composition(s), process of preparing the extracts useful for preparing herbal formulation to treat ulcers.
BACKGROUND ART
Peptic ulcer represents a major health problem, both in terms of morbidity and mortality.
FIELD OF INVENTION
The present invention relates generally to methods of treating disorders such as AIDS, arthritis (rheumatoid arthritis, osteoarthritis, spondyloarthropathies), antibiotic induced diarrheal diseases (Clostridium difficile), multiple sclerosis, osteoporosis, gingivitis, peptic ulcer
TECHNICAL FIELD
The present invention relates to glutamate (glutamic acid ester) derivatives having a CaSR agonist activity or pharmaceutically acceptable salts thereof; and CaSR agonist agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea, preventive or therapeutic
TECHNICAL FIELD
The present invention relates to a pharmaceutical agent containing (S)-1-cyclopropyl-1,4-dihydro-7-[2-(N,N-dimethylaminomethyl)morpholino]-6- fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof, which agent is useful for the prophylaxis and
FIELD OF THE INVENTION
The present invention relates to compositions for preventing and treating digestive organs diseases, especially, compositions for preventing and/or treating gastric ulcer, duodenal ulcer, gastritis, diarrhea, enteritis and the like.
BACKGROUND OF THE INVENTION
Peptic ulcer
FIELD OF THE INVENTION
This invention relates to the use of a composition containing extracts of Buddleja globosa Hope and pharmacologically accepted additives for the treatment or prevention of several gastrointestinal disorders, particularly those associated with patient treatment with
FIELD OF THE INVENTION
The present invention relates to a peptide derivative with a PAR-2-activating action or a salt thereof, and a pharmaceutical composition comprising the same as the effective ingredient. More specifically, the invention relates to a PAR-2-activating agent. Still more